These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38603533)

  • 1. Trends in low-value cancer care during the COVID-19 pandemic.
    Parikh RB; Civelek Y; Ozluk P; Debono D; Fisch MJ; Sylwestrzak G; Bekelman JE; Schwartz AL
    Am J Manag Care; 2024 Apr; 30(4):186-190. PubMed ID: 38603533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in US Ambulatory Care Patterns During the COVID-19 Pandemic, 2019-2021.
    Mafi JN; Craff M; Vangala S; Pu T; Skinner D; Tabatabai-Yazdi C; Nelson A; Reid R; Agniel D; Tseng CH; Sarkisian C; Damberg CL; Kahn KL
    JAMA; 2022 Jan; 327(3):237-247. PubMed ID: 35040886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
    Chen RC; Haynes K; Du S; Barron J; Katz AJ
    JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Utilization Management Policy With Uptake of Hypofractionated Radiotherapy Among Patients With Early-Stage Breast Cancer.
    Parikh RB; Fishman E; Chi W; Zimmerman RP; Gupta A; Barron JJ; Sylwestrzak G; Bekelman JE
    JAMA Oncol; 2020 Jun; 6(6):839-846. PubMed ID: 32297905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast and Lung Cancer Screening Among Medicare Enrollees During the COVID-19 Pandemic.
    Doan C; Li S; Goodwin JS
    JAMA Netw Open; 2023 Feb; 6(2):e2255589. PubMed ID: 36735262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
    Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
    JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes.
    Taylor EA; Cantor JH; Bradford AC; Simon K; Stein BD
    JAMA Netw Open; 2023 May; 6(5):e2314328. PubMed ID: 37204793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Acuity Alcohol-Related Complications During the COVID-19 Pandemic.
    Shuey B; Halbisen A; Lakoma M; Zhang F; Argetsinger S; Williams EC; Druss BG; Wen H; Wharam JF
    JAMA Health Forum; 2024 Apr; 5(4):e240501. PubMed ID: 38607643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term health care costs following COVID-19: implications for pandemic preparedness.
    Chambers LC; Park A; Cole M; Lovgren L; Zandstra T; Beaudoin FL; Collins M
    Am J Manag Care; 2023 Nov; 29(11):566-572. PubMed ID: 37948643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
    Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
    J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
    Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
    JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment.
    Han X; Yang NN; Nogueira L; Jiang C; Wagle NS; Zhao J; Shi KS; Fan Q; Schafer E; Yabroff KR; Jemal A
    Lancet Oncol; 2023 Aug; 24(8):855-867. PubMed ID: 37541271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic.
    Hailu R; Mehrotra A; Huskamp HA; Busch AB; Barnett ML
    JAMA Netw Open; 2023 Jan; 6(1):e2252381. PubMed ID: 36692880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous impact of the COVID-19 pandemic on lung, colorectal and breast cancer incidence in Hungary: results from time series and panel data models.
    Elek P; Csanádi M; Fadgyas-Freyler P; Gervai N; Oross-Bécsi R; Szécsényi-Nagy B; Tatár M; Váradi B; Zemplényi A
    BMJ Open; 2022 Aug; 12(8):e061941. PubMed ID: 35981776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes for Out-of-Hospital Cardiac Arrest in the United States During the Coronavirus Disease 2019 Pandemic.
    Chan PS; Girotra S; Tang Y; Al-Araji R; Nallamothu BK; McNally B
    JAMA Cardiol; 2021 Mar; 6(3):296-303. PubMed ID: 33188678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic.
    Nguyen T; Ziedan E; Simon K; Miles J; Crystal S; Samples H; Gupta S
    JAMA Netw Open; 2022 Jun; 5(6):e2214765. PubMed ID: 35648400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer diagnosis and treatment during the COVID-19 pandemic in a nationwide, insured population.
    Caswell-Jin JL; Shafaee MN; Xiao L; Liu M; John EM; Bondy ML; Kurian AW
    Breast Cancer Res Treat; 2022 Jul; 194(2):475-482. PubMed ID: 35624175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance.
    DiStefano MJ; Kang SY; Parasrampuria S; Anderson GF
    JAMA Health Forum; 2023 May; 4(5):e231090. PubMed ID: 37234016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between the COVID-19 Pandemic and Insurance-Based Disparities in Mortality After Major Surgery Among US Adults.
    Glance LG; Dick AW; Shippey E; McCormick PJ; Dutton R; Stone PW; Shang J; Lustik SJ; Lander HL; Gosev I; Joynt Maddox KE
    JAMA Netw Open; 2022 Jul; 5(7):e2222360. PubMed ID: 35849395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health Plan Enrollment and Disenrollment of Individuals With and Without Established Chronic Disease in a U.S. Commercially Insured and Medicare Advantage Population.
    Chung H; Deshpande G; Zolotarjova J; Quimbo RA; Kern DM; Cochetti PT; Willey VJ
    J Manag Care Spec Pharm; 2019 May; 25(5):612-620. PubMed ID: 31039058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.